President and Chief Executive Officer
Mr. Mirsaidi brings both practical and strategic senior management experience for young start-ups to fortune 100 companies, with proven track record in the industry. He held several senior level management positions in his ten-year career at Nichols Institute Diagnostics (a division of Quest Diagnostics). As general manager and executive director at Ontogen, a small molecule discovery company, he managed operations of a subsidiary focused on high throughput synthesis and purification of novel chemical compounds. Mr. Mirsaidi served as Vice President at AltheaDx, a spin-out from Althea Technologies, a San Diego biologics GMP manufacturing company, and most recently served as CEO and founder of Molecular Response, LLC, a CRO focused on translational oncology.
Over 20 years experience in senior management
Full P&L, Strategic Alliances, subsidiary and division operations, turnaround leadership
Founded Ahura Diagnostics (Acquired by NexGen Biotech)
Spun-off AltheaDx from Althea Technologies
Founded Molecular Response Laboratories